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Abstract
Background: Zika virus (ZIKV) has recently emerged as a teratogenic infectious agent associated with severe fetal
cerebral anomalies. Other microorganisms (TORCH agents) as well as genetic disorders and toxic agents may lead
to similar anomalies. In case of fetal anomalies, the exact etiology might be difficult to establish, especially in ZIKV
endemic countries. As the risks associated with maternal infection remain unclear adequate parental counseling is
difficult.
Case presentation: We present two cases of severe fetal pathologies managed in our multidisciplinary center
during the ZIKV outbreak in Martinique, a French Caribbean Island. Both fetuses had congenital ZIKV infection
confirmed by RT-PCR. While one case presented with significant cerebral anomalies, the other one presented
with hydrops fetalis. A complete analysis revealed that the fetal lesions observed resulted from a combination
of ZIKV congenital infection and a genetic disorder (trisomy 18) in case 1 or congenital Parvovirus B19
infection in case 2.
Conclusions: We highlight the difficulties related to adequate diagnosis in case of suspected ZIKV congenital
syndrome. Additional factors may contribute to or cause fetal pathology, even in the presence of a confirmed
ZIKV fetal infection. An exact diagnosis is mandatory to draw definitive conclusions. We further emphasize
that, similarly to other congenital infections, it is very likely that not all infected fetuses will become
symptomatic.
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Background
2016 has seen the emergence of Zika virus (ZIKV), a
member of the Flaviviridae family, as a teratogenic agent
associated with severe fetal malformations. Several other
microorganisms, grouped under the TORCH acronym
(Toxoplasmosis, Others [Syphilis, Parvovirus B19, Vari-
cella zoster, HIV], Rubella, Cytomegalovirus, Herpes), as
well as genetic disorders and toxic agents may lead to
similar anomalies [1].
Martinique is a French Caribbean Island that was af-
fected by the ZIKV epidemic at the end of 2015, and
presented one of the largest incidence rate among the
Caribbean, with an estimated 36,590 potential cases dur-
ing the epidemic [2]. To overcome the unknown risks of
fetal anomalies associated with maternal infection, the
French government implemented an active surveillance
of all pregnant women during the epidemic, with
monthly ultrasound examinations. In France, prenatal
screening for aneuploidy and serological screening are
offered to all pregnant patients during the first trimester.
Screening for congenital infections (i.e. TORCH screen-
ing) is proposed in cases of suspected maternal/fetal in-
fection. Blood was stored to allow retrospective serologic
analyses. We present here two cases of severe fetal path-
ologies resulting from a combination of ZIKV congenital
infection and either a genetic disorder or co-infection
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with Parvovirus B19, monitored in our reference center,
and highlight the need to obtain an exact diagnosis in
case of suspected ZIKV congenital syndrome.
Case presentation
Case 1
Patient 1 was a healthy 25-year-old primigravida woman
without any familial medical history. She experienced an
uneventful pregnancy until 23 + 5 weeks gestation (WG),
when the anatomical scan demonstrated a potential cleft
lip associated with dilatation of the left cerebral ventricle
and a short corpus callosum. The patient did not recall
any particular illness previously in her pregnancy (see
the Timeline presented in Fig. 1). The scan performed at
24 + 5 WG in our unit identified intra-uterine growth re-
striction (IUGR; <5th percentile) concurrent with mul-
tiple fetal anomalies including a bilateral cleft palate,
colpocephaly (both atriums measuring 10 mm), dysgene-
sis of the corpus callosum and enlargement of the cis-
terna magna (14 mm) associated with a posterior fossa
cyst (Fig. 2a and b). A diagnostic amniocentesis and fetal
blood sampling were performed at 25 + 5 WG for con-
genital infections and genetic analysis. Toxoplasmosis,
rubella and syphilis were previously excluded by negative
maternal serology. Due to the ongoing ZIKV epidemic,
ZIKV screening (RT-PCR RealStar® ZIKV RT-PCR Kit
1.0, Altona Diagnostics, Hamburg, Germany) was added
to the routine testing despite the absence of suggestive
symptoms in the mother. The amniotic fluid and fetal
blood were positive for ZIKV RNA confirming a
congenital ZIKV infection. Fetal biological parameters
(Table 1) also suggested fetal infection with elevated
total IgM (120 [<20 mg/l]); β2-Microglobulin 4.8
[<5 mg/ml]) and a cholestasis-like pattern (GGT 589
[<100 UI/l], AST 17 [<20 UI/l]), associated with moderate
anemia and thrombocytopenia (Hb 13.4 [>15 g/100 ml],
platelets 128 [>150 G/L]). However, maternal blood and
urine were negative for ZIKV RNA. We therefore per-
formed retrospective serum analysis, which confirmed a
maternal ZIKV infection that occurred between 5 + 3 and
14 + 3 WG (see Fig. 1). Fetal serological analyses were
negative for ZIKV IgM and equivocal for IgG, which may
have resulted from materno-fetal passage. Meanwhile, an
initial FISH analysis revealed mosaic trisomy 18 with 36%
of cells affected.
Due to the poor prognosis, the patient opted for ter-
mination of pregnancy as permitted by French legisla-
tion. At 29 + 5 WG, a stillborn male infant was delivered
with a weight of 870 g (<3rd percentile), head circumfer-
ence (HC) of 220 mm (<3rd percentile) and length of
36 cm, presenting with dysmorphic features: a large bi-
lateral cleft lip, peaked palate, exophthalmia and
hyperthelorism. At the time of delivery, fetal blood was
negative for ZIKV RNA, however it was amplified from
the cerebro-spinal fluid confirming ZIKV persistence in
the central nervous system despite systemic clearance.
Ultimately, cell culture and complete cytogenetic ana-
lysis confirmed the diagnostic of mosaic trisomy 18,
while CGH array did not reveal any additional genetic
anomalies. Autopsy was declined.
Case 2
Patient 2 was a 25-year-old healthy, gravida 4 para 2,
woman with a past history of stillbirth at 7 months ges-
tation of unknown etiology. Screening test for aneu-
ploidy was at low risk (1/10,000). At 19 + 5 WG, the
patient experienced a maculo-papular pruritic rash asso-
ciated with mild fever, arthralgia and headaches, compat-
ible with a viral infection. The anatomical scan at 22 + 5
WG showed hydrops fetalis with skin edema, ascites, a
large pericardial effusion and prefrontal edema
(5.9 mm), associated with symmetric IUGR (estimated
fetal weight 427 g; <3rd percentile, biparietal diameter
(BPD) of 44 mm (<3rd percentile), HC of 165 mm (<3rd
percentile), abdominal circumference of 193 mm (meas-
urement unreliable secondary to presence of ascites),
and femur length of 29.7 mm (<3rd percentile). No
morphological anomalies were detected (Fig. 2c and d).
Non-alloimmune fetal anemia was highly suspected.
Amniocentesis and fetal blood sampling were per-
formed, which confirmed severe fetal anemia and
thrombocytopenia (Table 1) (Hb 3.6 [>15 g/100 ml];
platelets 68 [>150 G/L]). Fetal blood transfusion was
performed. The amniotic fluid was positive for
PVB-19 DNA, while negative for ZIKV RNA and
CMV DNA. However, ZIKV RNA was detected in
fetal blood and placenta confirming a combined
PVB-19 and ZIKV fetal infection. Congruently, ZIKV
RNA was detected in both maternal blood and urine.
As persistent viremia has been described in pregnant
women [3], timing of maternal infection was con-
firmed based on retrospective serum analysis. The
identification of PVB-19 specific IgM at 13 + 5 WG,
while both ZIKV specific IgG and IgM were negative
confirmed a primary PVB-19 infection in the first tri-
mester (see Timeline presented in Fig. 1). Maternal
ZIKV infection occurred later and probably correlated
with maternal symptoms at 19 + 5 WG. These unspecific
symptoms could have corresponded to either a primary
ZIKV or PVB-19 infection. Fetal blood analysis revealed an
elevation of general inflammatory markers (β2-Microglobu-
lin 7.8 [mg/ml] (<5), total IgM 49 [mg/l] (<20)). Unlike case
1, the GGT remained low, while hepatic cytolysis was ob-
served (GGT 12 [UI/l] (<100), AST 96 [UI/l] (<20)). Due to
worsening fetal clinical status after transfusion (absent end
diastolic flow on umbilical artery Doppler, increasing
ascites, pericardial effusion and skin edema), the patient re-
quested medical termination of pregnancy, which was
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performed at 25 WG. A stillborn male infant weighing
530 g (<3rd percentile) presenting with significant edema
was delivered. No other macroscopic anomalies were noted.
Autopsy was declined.
Discussions and conclusions
We present two cases of severe fetal pathology. Al-
though fetal ZIKV infection was confirmed in both
cases, it is unclear whether the fetuses were symptomatic
Fig. 1 Monitoring over time. This figure represents clinical monitoring of two cases over time as well as specific outcomes. Abbreviations: Amnio,
Amniocentesis; FBS, Fetal blood sampling; Plac, Placenta; PVB-19, Parvovirus B19; ZIKV, Zika virus
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secondary to ZIKV infection or their other pathology.
We clearly showed that if Zika testing is positive, but the
fetal pathology does not clearly fit congenital ZIKV syn-
drome, more investigations are needed. Both trisomy 18
and ZIKV are known to cause microcephaly, IUGR, col-
pocephaly and dysgenesis of the corpus callosum as
observed in case 1 [4, 5]. Cleft palate has been described
as part as the Pierre-Robin-sequence in two fetuses ex-
posed to ZIKV during the French Polynesian outbreak,
though neither maternal nor fetal infections were con-
firmed [6]. This finding is probably unrelated to ZIKV
infection, which seems to have specific neurotropism.
Fig. 2 Specific ultrasound findings. This figure presents illustrative ultrasound scan images of Case 1 (a & b) and Case 2 (c & d). a Parasagittal
plane at 24 + 5 WG showing the dilatation of the posterior horn of the lateral ventricle (V), the atrophy of the cortical mantle (CM), as well as
enlarged peri-cerebral spaces, marked by an arrow. CP, choroid plexus. b Bilateral cleft palate observed at 27 + 6 WG on 3D reconstruction
ultrasound scan. c Axial plane at 22 + 5 WG showing normal heart with a diffuse pericardial effusion (*). d Transcerebellar axial plane at 23 + 4 WG
showing normal brain structures. Csp, Cavum spetum pellucidum; Cv, Cerebellar vermis, T, Thalami. Note the prefrontal edema (*)
Table 1 Biochemical and hematological fetal parameters
Normal
ranges
Case 1 Case 2
25 + 5 WG 29 + 5 WG 23 WG 25 WG
General parameters
Total IgM [mg/l] <20 120 70 ud. 49
β2-Microglobulin [mg/ml] <5 4.8 4.2 ud. 7.8
Liver function
GGT [UI/l] <100 589 672 ud. 12
AST [UI/l] <20 17 24 ud. 96
Albumin [g/l] 20–35 25.3 24.8 ud. 6.8
Total protein [g/l] 20–30 34 36 ud. 13
Hematological parameters
Hb [g/100 ml] >15 13.4 13.5 3.6 2.4
Platelets [G/L] >150 128 149 68 17
Abbreviation: ud. undetermined, WG = Weeks Gestation
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Interestingly, fetus 2 did not present with any cerebral
anomalies. Though structures were small for GA, in ac-
cordance with the symmetric IUGR, no additional
anomalies were seen. In particular, calcifications, ven-
triculomegaly and agenesis of the corpus callosum,
which have been commonly described in ZIKV in-
fected fetuses, were not observed [5]. Although two
cases [5, 7] have been reported with hydrops fetalis in
association with ZIKV fetal infection, it does not seem to
be a common finding. Furthermore, severe anemia and
thrombocytopenia have not been described in association
with ZIKV infection [3]. This suggests that PVB-19 infec-
tion was primarily responsible for the symptoms in fetus
2. The proximity of ZIKV infection to the TOP (late sec-
ond trimester) may explain the absence of cerebral anom-
alies, which could have developed later in gestation. This
may explain the negative amniocentesis, which despite
having been performed after 21 WG [8], the time lapse be-
tween maternal infection and amniocentesis (3 weeks)
may have been too short to observe viral excretion into
amniotic fluid.
Fetal risks associated with a maternal ZIKV infec-
tion remain unclear. Initial reports from Brazilian co-
horts suggested rates as high as 46% of adverse
outcomes in cases of ZIKV in utero exposure, inde-
pendent of the timing of exposure [9]. On the other
hand, more recent studies have failed to observed
similar results [10, 11]. Preliminary data from a re-
cent French Guyana cohort study suggest a much
lower rate with 1.7–3% of anomalies observed associ-
ated with first or second trimester infection only, des-
pite a transmission rate of 10.9% [12], while rates of
8, 5 and 4% of neurological anomalies (including
neural tube defects) have been reported in case of
RT-PCR confirmed maternal infection occurring dur-
ing first, second and third trimesters, respectively
[13]. The present work highlights the fact that despite
circulation of ZIKV virus, additional factors may con-
tribute to or cause fetal pathology, even in the pres-
ence of a confirmed ZIKV fetal infection. An exact
diagnosis is mandatory to draw definitive conclusions,
but may be difficult to obtain and requires invasive
materno-fetal procedures (ie. amniocentesis, fetal
blood sampling), as well as advanced microbiological and
genetic investigations. Similarly to other congenital infec-
tions, it is very likely that not all infected fetuses will be-
come symptomatic. By analogy with CMV, late maternal
infection may be associated with pauci- or asymptomatic
fetal disease despite higher transmission rates with advan-
cing GA (up to 60–70%) [14]. It is prudent to be reminded
that despite the wide distribution of CMV, severe congeni-
tal infections are only observed in 0.7% of pregnancies [14].
Although ZIKV harbors some specific characteristics, it
seems unlikely that the risk would be significantly higher.
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